雅虎香港 搜尋

搜尋結果

  1. 2024年5月15日 · SEATTLE, May 15, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the last patient in the Company’s Karisma-Endoxifen clinical trial received their final dose of study medication. Atossa is a clinical stage biopharmaceutical company developing innovative ...

  2. 2024年4月30日 · SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced the initiation of a Phase 2 investigator-sponsored trial (“IST”) of neoadjuvant radiation and e...

  3. 2024年5月14日 · 沙特阿拉伯,利雅得, May 14, 2024 (GLOBE NEWSWIRE) — 費薩爾國王專科醫院和研究中心 (King Faisal Specialist Hospital and Research Centre, KFSH&RC) 最近迎來了 Björn Zoéga 博士擔任其副 CEO,這一任命凸顯了醫院致力推動和培育卓越醫療保健的承諾。 Zoéga 博士以醫療管理和政策方面的豐富經驗而聞名,他加入了一個專職團隊,體現醫院持續推進的關鍵戰略舉措。 作為醫學研究和臨床服務的領導者,KFSH&RC 不斷吸引全球專家,努力實現卓越醫療的願景。 在 Zoéga 博士的參與下,醫院正在推進一項數碼轉型戰略,旨在提高營運效率並提升患者護理。

  4. 2024年5月14日 · SUNNYVALE, Calif., May 14, 2024 (GLOBE NEWSWIRE) — OpsMx, the secure software delivery company, today announced it has garnered recognition from three key industry award programs. OpsMx received a Bronze Stevie Award for OpsMx Delivery Shield in the DevOps Solution category.

  5. 2024年5月21日 · This is the first published paper of its kind demonstrating artificial intelligence analyzing unstructured clinical text within electronic health records to accurately support the automation and acceleration of cancer staging for complex head and neck cancers. TORONTO, May 21, 2024 (GLOBE NEWSWIRE) — HEALWELL AI Inc. (“ HEALWELL ” or the ...

  6. 2024年5月6日 · Anthony JoshuaIsrael Adesanya、Antoine Dupont、Ana Marković、Esteban Ocon 和 Peter Sagan 等領軍人物將參加這項獨特的網上交易比賽,比賽將於 2024 年 5 月 1 日至 5 月 31 日舉行。. 在 2023 年首屆 FlowBank 錦標賽取得巨大成功之後,這些體育偶像渴望展現自己的交易技巧,並向 ...

  7. 2024年5月29日 · Immediate opportunity to increase capacity for formulation and early asset development in upgraded Boston area R&D space. Non-cash deal includes royalty-free iSPERSE™ technology license in exchange for access to MannKind’s Cricket® inhaler. DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 29, 2024 (GLOBE NEWSWIRE) — MannKind ...